Its population consists of 723,515 inhabitants 13 , in an area of 211 475 km². Much of the city is situated on low-lying coastal plains, with an approximate elevation of 20 meters above the sea. According to the Brazilian Institute of Geography and Statistics (IBGE), its location is the Mesoregion of the Paraíba Forest, João Pessoa microrregion 14 .
The prevalence rates of MS in the world suggest the role of the interrelation between genetic and environmental factors 5 . Given the broad geographical spread and ethnic diversity of Brazil, it is believed that the frequency of MS varies between different regions 5 . In the state of Paraíba, there are no published studies to date on the epidemiological and clinical profile of multiple sclerosis. However, there are various ethnic groups that formed Paraíba's population. Before the arrival of the Portuguese, Paraiba was occupied by Potiguara and Tabajara Indians, and from the early sixteenth century, Europeans, predominantly Portuguese, colonized Paraíba. At the time of the Dutch invasion, between 1634 and 1654, there are reports of many inter-racial marriages. The black population had less presence in the formation of Paraíba population when compared to other states in the Northeast 15, 16 . According to the last census conducted by IBGE in 2010, from an ethnic-racial point-of-view, Paraíba has a population with a prevalence of mixed races (52.3%), followed by whites (42.6%), blacks (3.9%) and, finally, indigenous and yellows (0.36%), and those with no racial statement (0.79%) 13 . The aim of this study is to describe the clinical and epidemiological characteristics of patients diagnosed with MS living in the city of João Pessoa, Paraíba, Brazil.
METHOD
The model of this study was observational and retrospective descriptive, involving patients followed in the following care services to patients with multiple sclerosis in the city of João Pessoa . Only those patients dwelling in João Pessoa at the moment of theur diagnosis of MS were included in this study. Therefore, the geographical unit considered in this survey was the city of João Pessoa and its metropolitan area.
Data were collected according to the method proposed by the Latin American Committee for Treatment and Research in Multiple Sclerosis (LACTRIMS) 19 , from a review of medical records of patients. Participants were informed about the objectives and procedures of the study, and included in it after signing the consent form. Data were also collected from the IBGE 14 . This study was approved by the Ethics Committee in Research of the Lauro Wanderley University Hospital, under CAE 10897812.1.0000.5183, with the approval opinion no. 211 367.
The variables analyzed were gender, age, ethnicity, clinical presentation, patient age at diagnosis, patient age at first onset, time since diagnosis, duration of clinical manifestation of the disease, number of relapses, predominant symptoms, use of disease-modifying drugs and symptomatic drugs. The clinical presentation was defined based on the study of Lublin, in the categories relapsing-remitting (RR), secondary progressive (SP) and primary progressive (PP).
The assessment of functional capacity of patients was performed by the Expanded Scale of Incapacity State (Expanded Disability Status Scale or EDSS), the scale most often used to evaluate patients with multiple sclerosis. This scale has 20 items, with scores ranging from 0 to 10, and whose score increases along with the degree of patient impairment, with greater focus on the ability to ambulate 19, 20, 21 . We calculated mean and standard deviation for continuous variables, absolute and relative frequencies of categorical variables, calculus of the prevalence rate in the period, and its gender ratio. The prevalence day for analysis was July 27,2013. An analysis of simple linear Spearman correlation for quantitative variables was performed. Analyses were performed using the SPSS software, version 20.0 for Windows.
RESULTS
In the services for the care of patients with MS, there was a record of 164 patients diagnosed with the disease. Ouf of this number, 77 were excluded from the study due to their not living in the considered geographic unit, the City of João Pessoa, at the moment of diagnosis.
João Pessoa has an area of 211 475 km 2 and 723,515 inhabitants estimated on the prevalence day. A total of 87 patients were identified among the inhabitants of the city of João Pessoa, representing a prevalence of 12.0 cases/100,000 inhabitants. Out of 87 patients who were included in the study, 67 were women, verifying a ratio between females and males 3.3. Regarding ethnicity, 58 were white, 26 pheodermic and black 3. It was found that the most common clinical form of the disease in the sample relapsing-remitting (RR), 68 cases (78.2%), followed by the way secondary progressive (SP) (21.8%), and no patient had primary progressive (PP) manner.
The age, at which the diagnosis, was done age of first onset, and the time of diagnosis and duration of disease (clinical signs) was performed are shown in Table 1 .
Motor symptoms were most often presented by patients (65.5%), followed by cerebellar symptoms (35.6%), sensitive (33.3%), visual (32.2%) and those related to the brainstem (10.3%). We observed a positive correlation statistically significant of moderate magnitude between the number of outbreaks and the global score of the Expanded Disability Status Scale (EDSS) (rho = 0.38, p < 0.0005). There was a significant positive correlation, but small in magnitude, between this score and duration of disease (rho = 0.271, p = 0.011). Table 2 shows the clinical and demographic characteristics of patients according to ethnicity. There were no statistically significant differences between the clinical categories evaluated. However, there was greater distribution of women among white patients, while the opposite occurred among pheodermic.
The disease modifying drug most used by the patients was beta interferon at various doses (Figure) . Most patients did not use any symptomatic medication (78.2%) to alleviate the symptoms of the disease like depression, paresthesia, spasticity and urinary incontinence. Those using symptomatic drugs used amantadine hydrochloride (5.7%), fluoxetine (4.0%), baclofen (3.4%) and gabapentin (1.7%). Other medications, at lower frequencies, were used by 6.9% of patients.
DISCUSSION
In the city of João Pessoa, the prevalence of MS was found to be 12 cases per 100,000 inhabitants, conforming an area of average prevalence of the disease, according to studies by Kurtzke 21, 22, 23 , 24, 25 , however, it is not compatible with the findings of the study conducted in Recife, Pernambuco, Brazil, 130 km north of João Pessoa, in 2004 by presenting the latter a rate significantly below the other reported in the literature (Table 3) .
This low prevalence found in the study by Ferreira et al. may be related to the fact that this research was conducted at a single referral center in the geographical unit considered 6 . Moreover, one can also consider that there are difficulties in accessing health services and referral to specialist neurologists, beyond the problem of obtaining additional tests to support the diagnosis of MS, factors that may underestimate the actual number of cases. In addition, the comparisons between the capital, one should take into account the differences in the periods of data collection.
White ethnicity was predominant, corroborating most epidemiological studies in Brazil 2, 3, 4, 5, 10, 24, 25, 26 , except for the study of Ferreira et al. 6 , in which 93.2% were mixed race (African descent). In this respect, classifying patients according to their ethnicity in a country with great miscegenation as Brazil is not an easy task. We had difficulty in classifying patients as pheodermic, black or mulatto 1, 3 . The calculation of the sex ratio also indicated a greater predisposition of females to MS. A similar finding is reported in other studies on clinical and epidemiological profile of patients with the disease.
The age average and the first outbreak average of patients, the average disease duration in years, the average number of outbreaks, the average of the EDSS global score, as well as the predominance of RR are consistent with the literature [2] [3] [4] [5] 10, 24, 26 . The diagnosis time in years was greater than the Swedish study Skoog et al. 27 , in which the time was two years, while in this study it was 3.9 years. However, this date can be explained by the fact that Sweden is a country with wide access to health and wide availability of complementary tests, compared to those observed in Brazil. Nowadays 44.0 ± 14 39.0 ± 12 48 ± 18 NS Disease duration (years -average, SD) 12 ± 9 8 ± 5 13 ± 11 NS Number of outbreaks (average, SD) 3 ± 1 3 ± 1 3 ± 1 NS Age at 1st onset (average, SD) 32 ± 12 32 ± 10 35 ± 16 NS Time of diagnosis (years -average, SD) 5 ± 7 2 ± 3 8 ± 10 NS RR: Relapsing-remitting; SP: Secondary progressive; PP: Primary-Progressive; EDSS: Expanded Disability Status Scale; SD: standard deviation; NS: Not statistically significant (p < 0.05).
the diagnosis is more easily performed due to more access diagnostic tools. In addition there is increased life expectancy, that contributes for increased of prevalence rate.
The prevalence of motor, cerebellar, sensory and visual symptoms was also observed in other samples 2, 4 . The correlations observed between functional capacity assessed by the EDSS score, despite not reaching statistical significance in studies of Arruda et al. 24 . and Ferreira et al. 6 . The correlation observed in this study corroborates most international studies, which shows that the natural course of multiple sclerosis over the years, if not promptly treated with disease-modifying drugs, is associated to the accumulation of neurological deficits
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. Patients with the RR form may develop neurological disabilities gradually, often due to the inability to complete recovery of an outbreak 20 . In the study cohort, Skoog et al., 202 patients having the relapsing-remitting clinical form progressed to secondary progressive form, at an interval of 12 years, progressing with increased EDSS score 27 . However, in this same study, it is suggested that the best parameter to predict the disabilities that the disease can cause is the disease progression index, not the EDSS, considering the latter, after several outbreaks of the disease, can suffer influence of random factors 23, 27, 28 .
Regarding the distribution of disease modifying drugs among patients, there were similar results when compared to those found in the study by Cardoso et al. 1 We did not find, even in the most recent studies of clinical and epidemiological profile of MS, the use of Natalizumab, a humanized monoclonal antibody, a drug already in use by the participants of this study, since it is a drug with recent availability in the market.
It is important to emphasize the limitations of this study, especially the fact that it is a retrospective study and convenience sampling may reduce its external validity. Since these estimates are based on data from a capital, they do not reflect the situation of the state or the region as a whole. However, the aim of this study was to describe the clinical and epidemiological characteristics of patients with MS in the city of João Pessoa, where there is a major referral center for the treatment of MS for patients from all over the state, which allowed to cover the observation of the vast majority of patients with the disease in the city. We expect to contribute to the descriptive epidemiological study of MS, and encourage researchers to develop more studies on this disease in different regions of Brazil, especially in the Northeast, a region with limited research on this topic and its wide ethnic diversity. Figure. 
